Neogenomics (NEO) Treasury Shares (2011 - 2026)

Neogenomics has reported Treasury Shares for 16 years, with the latest figure at $3.7 million in Q1 2026.

• For the quarter ending Q1 2026, Treasury Shares rose 7.62% year-over-year to $3.7 million; the trailing twelve-month figure through Mar 2026 stood at $3.7 million (up 7.62% YoY), and the FY2025 full-year result was $552208.0, down 74.48% from the prior year.
• Treasury Shares for Q1 2026 stood at $3.7 million, up from $552208.0 in the prior quarter.
• The five-year high for Treasury Shares was $3.7 million in Q1 2026, with the low at $305105.0 in Q3 2023.
• Historically, Treasury Shares has averaged $2.0 million across 5 years, with a median of $2.1 million in 2023.
• Annual changes were most pronounced in 2023 — Treasury Shares plunged 84.71% — and 2025, when it surged 366.55%.
• Neogenomics' Treasury Shares stood at $2.0 million in 2022, then decreased by 1.65% to $2.0 million in 2023, then increased by 10.3% to $2.2 million in 2024, then slumped by 74.48% to $552208.0 in 2025, then surged by 575.1% to $3.7 million in 2026.
• The last three Treasury Shares figures came in at $3.7 million (Q1 2026), $552208.0 (Q4 2025), and $3.0 million (Q3 2025), per Business Quant data.